Welcome by
Dubravka Šuica
Member of Parliament
MEPs against Cancer (MAC)
Professor Chris Chapple
Secretary General
European Association of Urology (EAU)
“To raise the level of urological care”
The impact of PCa on the European Society
Prostate cancer is the most common cancer in Europe for males
• Each year 417.000 men in Europe are diagnosed with prostate cancer
• 1 in 7 men in Europe will develop prostate cancer before the age of 85
• More than two million men living with prostate cancer
• 92.200 European men die of the disease every year
• The yearly costs of PCa in Europe is over 9 billion euros
The impact of PCa – Regional Differences
The expectations
Health care burden of PCa is expected to
increase dramatically the coming years in
Europe:
• Ageing society will lead to higher
incidence and thus prevalence
• As a result the costs related to
PCa will increase significantly
• The decreasing mortality rate from
PCa has come to a stop
Now is the time to give Prostate Cancer Care priority at EU level!
The policy paper
• Recent evidence demonstrates the efficacy
of prostate cancer screening
• Worrying statistics on prostate cancer
mortality where prostate cancer screening
has been cut back
• Improved Quality of Life
• The availability of gold standard good
practice and emerging new technologies
Together we care
Thank you
Follow Us
www.uroweb.org
Become an EAU Member
Like Us on Facebook
Follow Us on Twitter
www.facebook.com/EAUpage
@uroweb

Chris Chapple: Welcome

  • 1.
    Welcome by Dubravka Šuica Memberof Parliament MEPs against Cancer (MAC) Professor Chris Chapple Secretary General European Association of Urology (EAU)
  • 2.
    “To raise thelevel of urological care”
  • 3.
    The impact ofPCa on the European Society Prostate cancer is the most common cancer in Europe for males • Each year 417.000 men in Europe are diagnosed with prostate cancer • 1 in 7 men in Europe will develop prostate cancer before the age of 85 • More than two million men living with prostate cancer • 92.200 European men die of the disease every year • The yearly costs of PCa in Europe is over 9 billion euros
  • 4.
    The impact ofPCa – Regional Differences
  • 5.
    The expectations Health careburden of PCa is expected to increase dramatically the coming years in Europe: • Ageing society will lead to higher incidence and thus prevalence • As a result the costs related to PCa will increase significantly • The decreasing mortality rate from PCa has come to a stop Now is the time to give Prostate Cancer Care priority at EU level!
  • 6.
    The policy paper •Recent evidence demonstrates the efficacy of prostate cancer screening • Worrying statistics on prostate cancer mortality where prostate cancer screening has been cut back • Improved Quality of Life • The availability of gold standard good practice and emerging new technologies
  • 7.
  • 8.
    Follow Us www.uroweb.org Become anEAU Member Like Us on Facebook Follow Us on Twitter www.facebook.com/EAUpage @uroweb